Focused Wealth Management Inc lowered its stake in Colgate-Palmolive (NYSE:CL) by 22.9% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 4,749 shares of the company’s stock after selling 1,410 shares during the quarter. Focused Wealth Management Inc’s holdings in Colgate-Palmolive were worth $325,000 at the end of the most recent reporting period.
Several other large investors also recently added to or reduced their stakes in the company. Capital Financial Planning LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $27,000. Timber Creek Capital Management LLC grew its position in Colgate-Palmolive by 247.1% in the 4th quarter. Timber Creek Capital Management LLC now owns 472 shares of the company’s stock valued at $28,000 after purchasing an additional 336 shares during the period. Parisi Gray Wealth Management grew its position in Colgate-Palmolive by 365.3% in the 4th quarter. Parisi Gray Wealth Management now owns 470 shares of the company’s stock valued at $28,000 after purchasing an additional 369 shares during the period. Portfolio Solutions LLC acquired a new stake in Colgate-Palmolive in the 4th quarter valued at $30,000. Finally, WP Advisors LLC acquired a new stake in Colgate-Palmolive in the 1st quarter valued at $34,000. Institutional investors own 75.95% of the company’s stock.
CL opened at $71.15 on Thursday. The company has a current ratio of 1.07, a quick ratio of 0.74 and a debt-to-equity ratio of 32.25. The firm has a market cap of $61.44 billion, a price-to-earnings ratio of 23.96, a PEG ratio of 4.69 and a beta of 0.81. Colgate-Palmolive has a 1 year low of $57.41 and a 1 year high of $72.85.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, April 26th. The company reported $0.67 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.66 by $0.01. The company had revenue of $3.88 billion for the quarter, compared to the consensus estimate of $3.86 billion. Colgate-Palmolive had a net margin of 15.08% and a negative return on equity of 3,730.37%. The firm’s quarterly revenue was down 2.9% on a year-over-year basis. During the same period in the previous year, the firm earned $0.74 EPS. On average, analysts expect that Colgate-Palmolive will post 2.83 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a $0.43 dividend. This is an increase from Colgate-Palmolive’s previous quarterly dividend of $0.42. This represents a $1.72 dividend on an annualized basis and a dividend yield of 2.42%. The ex-dividend date of this dividend was Wednesday, April 17th. Colgate-Palmolive’s payout ratio is 57.91%.
CL has been the topic of a number of analyst reports. Jefferies Financial Group reaffirmed a “hold” rating and set a $61.00 price objective on shares of Colgate-Palmolive in a report on Friday, February 1st. Zacks Investment Research downgraded shares of Colgate-Palmolive from a “hold” rating to a “strong sell” rating in a report on Wednesday, January 30th. BNP Paribas raised shares of Colgate-Palmolive from an “underperform” rating to a “neutral” rating and lifted their price objective for the stock from $56.00 to $67.00 in a report on Monday, February 11th. Wells Fargo & Co reaffirmed a “hold” rating and set a $57.00 price objective on shares of Colgate-Palmolive in a report on Friday, January 25th. Finally, Macquarie set a $57.00 price objective on shares of Colgate-Palmolive and gave the stock a “hold” rating in a report on Tuesday, January 29th. One equities research analyst has rated the stock with a sell rating, thirteen have given a hold rating and five have given a buy rating to the company. The stock has an average rating of “Hold” and an average price target of $69.69.
In related news, VP Justin Skala sold 92,643 shares of the business’s stock in a transaction dated Tuesday, May 7th. The shares were sold at an average price of $70.78, for a total value of $6,557,271.54. Following the transaction, the vice president now directly owns 163,653 shares of the company’s stock, valued at approximately $11,583,359.34. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Jennifer Daniels sold 3,498 shares of the business’s stock in a transaction dated Tuesday, February 19th. The stock was sold at an average price of $66.39, for a total transaction of $232,232.22. Following the completion of the transaction, the insider now directly owns 38,824 shares in the company, valued at $2,577,525.36. The disclosure for this sale can be found here. Insiders sold a total of 352,831 shares of company stock worth $24,752,192 over the last three months. 1.14% of the stock is owned by insiders.
COPYRIGHT VIOLATION NOTICE: This news story was first published by Highlight Press and is the sole property of of Highlight Press. If you are viewing this news story on another publication, it was copied illegally and reposted in violation of U.S. & international copyright legislation. The original version of this news story can be viewed at https://highlightpress.com/2019/05/16/colgate-palmolive-cl-shares-sold-by-focused-wealth-management-inc.html.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products worldwide. The company operates through two segments, Oral, Personal and Home Care; and Pet Nutrition. It offers oral care products, including toothpastes, toothbrushes, and mouthwashes, as well as pharmaceutical products for dentists and other oral health professionals; and personal care products, such as liquid hand soaps, bar soaps, shower gels, deodorants and antiperspirants, skin care products, and shampoos and conditioners.
Featured Story: Google Finance Portfolio Workaround
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.